Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
2.700
-0.010 (-0.37%)
Aug 15, 2025, 4:10 PM AEST

Australian Clinical Labs Company Description

Australian Clinical Labs Limited provides pathology diagnostic services in Australia.

The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.

It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Australian Clinical Labs Limited
CountryAustralia
Founded2020
IndustryDiagnostics & Research
SectorHealthcare
Employees4,900
CEOMelinda McGrath

Contact Details

Address:
1868-1892 Dandenong Road
Clayton, 3168
Australia
Phone61 1 3004 53688
Websiteclinicallabs.com.au

Stock Details

Ticker SymbolACL
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000148496
SIC Code8071

Key Executives

NamePosition
Shae SeymourChief Executive Officer of WA/SA/NT
Chris BrownlowChief Executive Officer of New South Wales and Australian Capital Territory
Darren McKeeChief Executive Officer of Victoria
Melinda McGrathChief Executive Officer and Executive Director
Matthew CordingleyChief Financial Officer
Anthony FriedliChief Operating Officer
Sean JacksonChief Information Officer
Joe GeranNational Marketing Director
Associate Prof. Tony LandgrenNational Medical Director and Chief Pathologist
Eleanor Padman B.A., FCISCompany Secretary